IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS WITH R-PCR (REAL TIME POLYMERASE CHAIN REACTION) TECHNIQUE FOR DIAGNOSIS OF PULMONARY TB PATIENTS BALKESMAS SEMARANG
Abstract
Tuberculosis is one of the causes of death due to infection and is transmitted globally by more than 10 million people. Pulmonary tuberculosis (TB) is an infectious disease which is a priority health problem in developing countries, including Indonesia. 16 countries accounted for 93% of tuberculosis cases with 3 countries contributing the most tuberculosis cases namely India, Indonesia and the Philippines. It is very important to develop methods to increase the sensitivity and specificity of TB examination results using the r-PCR (real time polymerase chain reaction) technique. This process requires a double-stranded DNA template containing target DNA, DNA polymerase enzyme, triphosphate nucleotides, and a pair primer.which has better accuracy and precision by using IS6 and IS7 primer. To determine the sensitivity and specificity of the R-PCR (REAL TIME POLYMERASE CHAIN REACTION) TECHNIQUE method. This research is non-experimental analytic in nature. The sample used in this study was a pure culture of Mycobacterium tuberculosis growth in the National Health Service Office of Central Java Province with microscopic testing AFB staining, R-PCR ( REAL TIME POLYMERASE CHAIN REACTION). The results showed that there was no difference between the conventional culture identification method as the standard for identification of Mycobacterium tuberculosis and the results of RT PCR examination with IS6110 primer having 100% sensitivity and specificity.
Kata Kunci : Mycobacterium tuberculosis, kultur , RT – PCR
Full Text:
PDFReferences
Coscolla, M. & Gagneux, S., 2014, ‘Consequences of genomic diversity in mycobacterium tuberculosis’, Seminars in Immunology, 26(6), 431–444.
Desjardin, L.E., Chen, Y., Perkins, M.D., Teixeira, L., Cave, M.D. & Eisenach, K.D., 1998, ‘Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis’, Journal of Clinical Microbiology, 36(7), 1964–1968.
Dheda, K., Perumal, T., Moultrie, H., Perumal, R., Esmail, A., Scott, A.J., Udwadia, Z., Chang, K.C., Peter, J., Pooran, A., Delft, A. von, Delft, D. von, Martinson, N., Loveday, M., Charalambous, S., Kachingwe, E., Jassat, W., Cohen, C., Tempia, S., Fennelly, K. & Pai, M., 2022, ‘The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions’, The Lancet Respiratory Medicine, 2600(22), 1–20.
Embden, J.A.N.D.A.V.A.N., Cave, M.D., Crawford, J.T., Dale, J.W., Eisenach, K.D., Gicquel, B., Hermans, P., Martin, C., Mcadam, R., Shinnick, T.M. & Small, P.M., 1993, ‘Strain Identification of Mycobacterium tuberculosis by DNA Fingerprinting : Recommendations for a Standardized Methodology’, 31(2), 406–409.
Gharbi, R., Mhenni, B., Fraj, S. Ben & Mardassi, H., 2019, ‘Nontuberculous mycobacteria isolated from specimens of pulmonary tuberculosis suspects, Northern Tunisia: 2002-2016’, BMC Infectious Diseases, 19(1), 1–11.
Harta Wedari, N.L.P., Pranata, I.W.A., Budayanti, N.N.S. & Sukrama, I.D.M., 2021, ‘Tuberculosis cases comparison in developed country (Australia) and developing country (Indonesia): a comprehensive review from clinical, epidemiological, and microbiological aspects’, Intisari Sains Medis, 12(2), 421.
Hatami, H., Sotgiu, G., Bostanghadiri, N., Abadi, S.S.D., Mesgarpour, B., Goudarzi, H., Migliori, G.B. & Nasiri, M.J., 2022, ‘Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis’, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 48(2), e20210384.
Holani, A.G., Ganvir, S.M., Shah, N.N., Bansode, S.C., Shende, V., Jawade, R. & Bijjargi, S.C., 2014, ‘Demonstration of Mycobacterium Tuberculosis in sputum and saliva smears of tuberculosis patients using Ziehl Neelsen and flurochrome staining - A comparative study’, Journal of Clinical and Diagnostic Research, 8(7), 42–45.
Kassaza, K., Orikiriza, P., Llosa, A., Bazira, J., Nyehangane, D., Page, A.L. & Boum, Y., 2014, ‘Lowenstein-Jensen selective medium for reducing contamination in Mycobacterium tuberculosis culture’, Journal of Clinical Microbiology, 52(7), 2671–2673.
Nurjana, M.A., Gunawan, G., Tjandrarini, D.H. & Nainggolan, O., 2020, ‘The Relationship between External and Internal Risk Factors with Pulmonary Tuberculosis in Children Aged 0-59 Months in Slums in Indonesia, 2013’, Global Journal of Health Science, 12(11), 116.
Parums, D. V., 2021, ‘Editorial: Updates from the world health organization (who) on global treatment recommendations for drug-susceptible and multidrug-resistant tuberculosis’, Medical Science Monitor, 27, 1–3.
Rahmat Ullah, S., Majid, M., Rashid, M.I., Mehmood, K. & Andleeb, S., 2021, ‘Immunoinformatics Driven Prediction of Multiepitopic Vaccine Against Klebsiella pneumoniae and Mycobacterium tuberculosis Coinfection and Its Validation via In Silico Expression’, International Journal of Peptide Research and Therapeutics, 27(2), 987–999.
SHARMA, S., 2020, ‘Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases’, Journal of dental education, 152(3), 185–226.
Widodo, W., Irianto, A. & Pramono, H., 2017, ‘Karakteristik Morfologi Mycobacterium tuberculosis yang Terpapar Obat Anti TB Isoniazid (INH) secara Morfologi’, Biosfera, 33(3), 109.
Widodo, W. & Priyatno, D., 2020, ‘DETECTION OF THE RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS FROM SPECIMENS WITH TB PATIENTS IN SEMARANG BALKESMAS’, Jurnal Riset Kesehatan.
World Health Organization, 2021, ‘Treatment of drug-susceptible tuberculosis : rapid communication’, (June), 1–4.
/ ICPSR36966.v1
DOI: https://doi.org/10.33992/icmahs.v1i1.2956
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
POLTEKKES KEMENKES DENPASAR
Address: Jl. Sanitasi No.1, Sidakarya, Denpasar Selatan, Kota Denpasar, Bali 80224 (0361) 710447